Cost-of-illness analysis reveals potential healthcare savings with reductions in type 2 diabetes and cardiovascular disease following recommended intakes of dietary fiber in Canada

Frontiers in Pharmacology
Mohammad M H AbdullahPeter J H Jones

Abstract

Type 2 diabetes (T2D) and cardiovascular disease (CVD) are leading causes of mortality and two of the most costly diet-related ailments worldwide. Consumption of fiber-rich diets has been repeatedly associated with favorable impacts on these co-epidemics, however, the healthcare cost-related economic value of altered dietary fiber intakes remains poorly understood. In this study, we estimated the annual cost savings accruing to the Canadian healthcare system in association with reductions in T2D and CVD rates, separately, following increased intakes of dietary fiber by adults. A three-step cost-of-illness analysis was conducted to identify the percentage of individuals expected to consume fiber-rich diets in Canada, estimate increased fiber intakes in relation to T2D and CVD reduction rates, and independently assess the potential annual savings in healthcare costs associated with the reductions in rates of these two epidemics. The economic model employed a sensitivity analysis of four scenarios (universal, optimistic, pessimistic, and very pessimistic) to cover a range of assumptions within each step. Non-trivial healthcare and related savings of CAD$35.9-$718.8 million in T2D costs and CAD$64.8 million-$1.3 billion in CVD cost...Continue Reading

References

Feb 24, 1999·JAMA : the Journal of the American Medical Association·R R RobertsR J Rydman
Sep 9, 1999·The American Journal of Clinical Nutrition·S LiuW C Willett
Apr 4, 2003·JAMA : the Journal of the American Medical Association·Dariush MozaffarianDavid S Siscovick
May 13, 2003·The Proceedings of the Nutrition Society·Maureen A MurtaughLeonard Marquart
Nov 11, 2003·The Journal of Nutrition·Anwar T MerchantAlberto Ascherio
Jan 1, 2004·American Journal of Hypertension·David A McCarron, Robert P Heaney
Feb 26, 2004·Archives of Internal Medicine·Mark A PereiraAlberto Ascherio
Sep 29, 2004·American Journal of Preventive Medicine·John Cawley
Dec 9, 2004·The American Journal of Clinical Nutrition·James W Anderson
May 4, 2006·Alimentary Pharmacology & Therapeutics·L PetruzzielloG Costamagna
May 16, 2007·Archives of Internal Medicine·Matthias B SchulzeHeiner Boeing
Jun 11, 2008·The American Journal of Clinical Nutrition·Tamara DubowitzJosé J Escarce
Jul 16, 2009·American Journal of Health Promotion : AJHP·Timothy M DallJames D Astwood
Jan 22, 2010·The New England Journal of Medicine·Kirsten Bibbins-DomingoLee Goldman
Sep 17, 2010·Public Health Nutrition·Sinéad BoylanMartin Bobak
Oct 14, 2010·Food & Nutrition Research·Collin L GylesPeter J H Jones
Jan 12, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D AuneT Norat
Oct 18, 2012·European Journal of Clinical Nutrition·G-C ChenQ-F Liu
Dec 4, 2013·BMC Public Health·Jørgen Dejgård Jensen, Sanne Kellebjerg Poulsen
Dec 21, 2013·BMJ : British Medical Journal·Diane E ThreapletonVictoria J Burley
Jul 8, 2015·The British Journal of Nutrition·Mariette Gerber, Richard Hoffman

❮ Previous
Next ❯

Citations

Oct 23, 2019·Nutrients·Olivia K LoewenPaul J Veugelers
Nov 30, 2018·Nutrients·Mark L Dreher

❮ Previous
Next ❯

Software Mentioned

InterAct

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.